MS Patients Show Robust T-Cell Response to mRNA COVID-19 Vaccines
MS patients receiving anti-CD20 monoclonal antibody treatment can still mount T-cell responses
Neurologic Disorders
Most With AD, MCI Would Have Been Excluded From Aducanumab Clinical Trials
Overall, 92.2, 91.0, and 85.5 percent of Medicare beneficiaries with ADRDs, Alzheimer disease, and MCI met at least one of the exclusion criteria
Less Screen Time After Concussion Tied to Faster Recovery
Those abstaining from screen time had nearly five days shorter duration of symptoms
Intraperitoneal Therapy Gets Orphan Drug Status for Hyperammonemia
VS-01 is a novel liposomal-based intraperitoneal fluid that acts as a clearance enhancer of toxic metabolites, in particular ammonia, from the body.
Briviact Approval Expanded to Include Younger Patients with Partial-Onset Seizures
Briviact is now indicated for the treatment of partial-onset seizures in patients 1 month of age and older.
Vagus Nerve Stimulation System Approved for Post Stroke Rehabilitation Therapy
The Vivistim System features an implantable pulse generator, which is placed just under the skin in the chest of the patient, and a lead wire.
Trial Evaluating Ravulizumab for Amyotrophic Lateral Sclerosis Discontinued
Following a prespecified interim analysis, the decision to halt the study was made based on the recommendation from the Independent Data Monitoring Committee.
Fifteen Headache-Day Threshold Does Not Capture Migraine Burden
Findings raise questions about the current headache frequency used for classification of migraine headaches
Complaint Prompts FDA Action on Use of Purple Patient Bracelets, Wristbands
The alert comes after a recent complaint about a purple wristband with a different meaning.
Oral Myosin Inhibitor Fast Tracked for Becker Muscular Dystrophy
EDG-5506 is a selective, small molecule myosin inhibitor designed to protect injury-susceptible fast skeletal muscle fibers.
